Navigation Links
Mayuka Labs R&D Centre Gets DSIR Recognition
Date:1/12/2009

NEW DELHI, India, January 12 /PRNewswire/ -- New Delhi based Mayuka Labs Private Limited has received recognition for its in-house research & development facility from the department of scientific and industrial research (DSIR) under the ministry of science and technology, Government of India.

With twenty-one scientists working round the clock at its R&D and Pilot unit at Nacharam, Mayuka Labs has crossed this milestone in its first year of operations. The company has filed two international PCT patents in 2008 and is working on new process technologies on 12 different molecules. The companies customer base ranges from big pharma clients like Boehringer Ingelheim to leading generic companies like Mylan subsidiary Matrix Labs, Dr. Reddy's and Unimark Remedies.

"We create value for our customers through innovative new processes. As Thomas Friedman put it, this is a flat and deeply interconnected world and our R&D teams work 24/7 to cater to customers across the world. The DSIR recognition for our R&D, is a key milestone as we continue to drive efficiencies in the Custom Research, Custom Synthesis and Custom Manufacturing space," said Dr.Chandra Sekhar N K, Chairman and Managing Director, Mayuka Labs.

With this accreditation, Mayuka Labs is entitled to receive support from government establishments such as Council of Scientific & Industrial Research (CSIR), Department of Biotechnology (DBT) and the Department of Science and Technology (DST) for its projects.

According to the DSIR website there are only one thousand two hundred and forty seven companies across all industries, including research labs set up by multi-national companies which are recognized by DSIR in India. Within the pharma and biotech space, there are less than two hundred. Mayuka Labs is now a part of this select group.

The Government recognition of its R&D center, apart from
'/>"/>

SOURCE Mayuka Labs Private Limited
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. YM BIOSCIENCES NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE
2. New nanotechnology centre helps turn big ideas into real products
3. VTT Technical Research Centre of Finland Licenses MetaCore from GeneGo for Cancer Research and Diagnostics
4. Canadian Centre for DNA Barcoding to Participate in Microchip Biotechnologies Early Access Program for Microchip-Based DNA Sample Preparation and Cycle Sequencing
5. New funding to charge energy research at UCL and the London Centre for Nanotechnology
6. European Centre for Modern Drug Discovery Established in Hamburg
7. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
8. Consistency, Flexibility Key in Improving Rewards & Recognition Programs
9. New VeriEye SDK from Neurotechnology Enables Development of Reliable, Cost-effective Biometric Iris Recognition Systems
10. Kiwa Holds 2007 Annual Management Meetings and Employee Recognition Ceremonies in Beijing
11. Synthetech Earns National Recognition for Performance Improvement Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... METTLER TOLEDO recently announc...Process Optimization Using At-Line Particle Charac..., 2009. In this webinar, the application of in si...p the design space and optimize a series of roller... rates, and roller compaction forces. , ...
(Date:11/19/2009)..., BLAUVELT, N.Y., Nov. 19 Dr. Ma...m extract, responds to a press release issued on N...garian company for making false and self-serving s...iences. ,, Dr. Hidvegi stated from his office ... that research on Avemar does not apply to AveULTR...
(Date:11/19/2009)... , MUNSTER, Germany, November 19 /PRNewswi...ave filed on November 16th, 2009 Flibanserin in th...yskinesia in Parkinson,s,disease for orphan drug s...cy,(EMEA). Levodopa-induced dyskinesia is a compli...nson,s and a serious burden to some of those,affec...
(Date:11/19/2009)... , VIENNA, Austria, November 19 /PRNewswi...ne program on one product candidate at an unexpect...date AD02 is planned to enter into,Phase II clinic...ny,immediately follows the completion of two Phase...ompany based its fast decision on the first interi...
Breaking Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
... Monday, March 10, 2008 at 8:30am, NEW YORK, Marc...icals, Inc. (Nasdaq: KERX ), announced top-line r...f Sulonex (sulodexide) for the,treatment of diabet...ase 3,clinical trial failed to meet the primary ob...oportion of patients that achieve therapeutic succ...
... Q3 2008 -, TORONTO, March 10 /PRNewswire-FirstCa... or the "Company"), a medical technology company,d...oday announced the,randomization of the 100th pati...e, double-blind placebo-controlled randomized clin...acy of Complex Neural Pulse,(CNP(TM)) therapy for ...
...,Anesiva, Inc. (Nasdaq: ANSV ) today announced th...ug Application (sNDA) with the U.S. Food and Drug,...Zingo to treat the pain,associated with peripheral...) (lidocaine hydrochloride monohydrate) powder int...he FDA to provide local analgesia,prior to periphe...
Other Biology Technology:Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 2Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 3Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 4Fralex reaches 100th patient milestone in fibromyalgia study 2Fralex reaches 100th patient milestone in fibromyalgia study 3Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 2Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 3Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 4
(Date:11/22/2009)...xposed prenatally to tobacco smoke and during chil...HD, according to research done at Cincinnati Child...ates that up to 35 percent of ADHD cases in childr...y eliminating both of these environmental exposure...n , "Tobacco and lead exposure each have their ...
(Date:11/22/2009)...ber 18, 2009 -- A butterfly,s proboscis looks like... but it works more like a paper towel, according t...s to borrow the tricks of this piece of insect ana...d inside of cells. , Kornev will present his wor...ican Physical Society,s (APS) Division of Fluid Dy...
(Date:11/20/2009)...t work on many scientific and technological fronti...provided support that totals nearly $4.3 million f...ors under the American Recovery and Reinvestment A...ed grants for investigation of solar phenomena. Ph... will enhance the capabilities of NJIT,s Big Bear ...
Breaking Biology News(10 mins):Exposure to lead, tobacco smoke raises risk of ADHD 2NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Possible Gene Regions for Schizophrenia Located 50567 1Possible Gene Regions for Schizophrenia Located 50567 2Oral Cancer Foundation Praised for Its Social Media Efforts 50564 1Oral Cancer Foundation Praised for Its Social Media Efforts 50564 2Nations First Eco Friendly Mobile Health Van Launched by New Jersey Non Profit Health Center 50561 1Nations First Eco Friendly Mobile Health Van Launched by New Jersey Non Profit Health Center 50561 2Nations First Eco Friendly Mobile Health Van Launched by New Jersey Non Profit Health Center 50561 3
...t Design theorists have in America be broken by th... American evolutionist, makes the case for Darwin ...ign? Reporting from the front lines of America,s s...oology at UCL (University College London) on 16th ... Florida State University, will argue that Intelli...
...oculate everyone in the United States could be gro...tobacco plants, a University of Central Florida mo... a vaccine produced in UCF professor Henry Daniell...obacco plants survived lethal doses of anthrax adm...esearchers. The results of the NIH-funded study ar...
... a special green-algae gene into neurons of the ti...ave been able to elicit specific behavioral respon.... The work paves the way for better understanding ...th muscles, to regulate behavior in intact, living...on about the activity and function of specific neu...
Other Biology News:'Creationism is not science' ?making the case for Darwin at UCL 2Effective, safe anthrax vaccine can be grown in tobacco plants 2Effective, safe anthrax vaccine can be grown in tobacco plants 3Algal protein in worm neurons allows remote control of behavior by light 2
...ction Kit provides an extremely fast and efficient...lexes. Unlike other systems that require tedious o...ystem takes advantage of the highly selective Stre...tion under physiological conditions with low backg...
Histidine-tagged Protein Purification Resin from R&D Systems
GIBCO AmnioMAX-C100 Basal Medium liquid from Invitrogen
...ynabeads Tosylactivated (4.5 m). Hydrophobic nake...roups. For coupling of antibodies for cell applica...itial coupling with covalent binding of primary am...urringovernight. Coupling reactions can be perform...
Biology Products: